GSK-205540

Study Sponsor: GSK

Study Title

A randomised, double-blind, placebo-controlled, parallel group, 8-week treatment study to investigate the safety, pharmacodynamics, and effect of the TLR7 agonist, GSK2245035, on the allergen-induced asthmatic response in subjects with mild allergic asthma

Medicine or Vaccine (generic name)

GSK2245035

Sponsor Identification Number

205540

Trial Registry Identification Number(#'s)

NCT02833974 2015-005645-31

Medical Condition

Asthma

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205540

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02833974

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2015-005645-31

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

January 2021